Effect of method of preparation on pioglitazone HCl-cyclodextrin inclusion complexes

Asian Journal of Pharmaceutics

Volumn 4, Issue 2, 2010, Pages 168-172

  Beloshet, Shrikant P ^a   Chougule, Dhanyakumar D ^a   Shah, Rohit R ^a   Ghodke, Dhananjay S ^a   Pawar, Nagnath D ^a   Ghaste, Rahul P ^a  

^a Appasaheb Birnale College of Pharmacy   (India)

Author keywords

cyclodextrin; Inclusion complex; pioglitazone HCl

Indexed keywords

BETA CYCLODEXTRIN; PIOGLITAZONE;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISSOLUTION; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; INFRARED RADIATION; INFRARED SPECTROSCOPY; MOLAR TOOTH; PARTITION COEFFICIENT; PRECIPITATION; SOLUBILITY; SPECTROSCOPY; THIN LAYER CHROMATOGRAPHY;

EID: 77956260626     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.68470     Document Type: Article

References (18)

1. Rao VM, Nerurkar M, Pinnamaneni S, Rinaldi F, Raghavan K. Co-solubilization of poorly soluble drugs by micellization and complexation. Int J Pharm 2006;319:98-106.
2. Thorsteinn L, Marcus E, Mar M. Role of cyclodextrins in improving oral drug delivery. Am J Drug Deliv 2004;2:1-15.
3. Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 2007;59:645-666
4. Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: An updated review. AAPS PharmSciTech 2005;6:E329-57.
5. Bibby DC, Davies NM, Tucker IG. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int J Pharm 2000;197:1-11.
6. Cal K, Centkowska K. Use of cyclodextrins in topical formulations: Practical aspects. Eur J Pharm Biopharm 2008;68:467-478
7. Braibanti A, Fisicaro E, Ghiozzi A, Compari C, Bovis G. Host-guest interactions between β-cyclodextrin and piroxicam. React Funct Polym 1998;36:25l-5.
8. Rai AK, Rai DK. Spectroscopic studies of some antidiabetic drugs. Spectrochim Acta A Mol Biomol Spectrosc 2003;59:1673-1680
9. Khalil R, Elbary A, Kassem M, Samra M. Formulation and hypoglycemic activity of pioglitazone-cyclodextrin inclusion complexes. Drug Discov Ther 2008;2:94-107.
10. Waleczek KJ, Marques HM, Hempel B, Schmidt PC. Phase solubility studies of pure (-)-alpha-bisabolol and camomile essential oil with beta-cyclodextrin. Eur J Pharm Biopharm 2003;55:247-251
11. Bhosale A, Hardikar S, Jagtap R, Patil, Dhawale S. Formulation of β-cyclodextrin complexed controlled release matrix tablets of glipizide and its in-vitro evaluation. Int J PharmTech Res 2009;1:773-778
12. Higuchi T, Connors K. Phase-solubility techniques. Adv Anal Chem Instrum 1965;4:117-212.
13. Vij M, Garse H, Dand N, Kadam V, Hirlekar R. Effect of preparation method on complexation of cefdinir with β-cyclodextrin. J Incl Phenom Macrocycl Chem 2009;11:1-9.
14. Sapkal N, Kilor V, Bhusari K, Daud A. Evaluation of some methods for preparing gliclazide-β-cyclodextrin inclusion complexes. Trop J Pharm Res 2007;6:833-840
15. Karthik A, Subramanian G, Rao M, Bhat K, Musmade P, Surulivelrajan M, Karthikeyan K, Udupa N. Simultaneous determination of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form by RP-HPLC method. Pak J Pharm Sci 2008;21:4215.
16. Suresh S, Shivakumar H, Kumar G. Effect of β-cyclodextrin complexation on solubility and dissolution rate of carbamazepine from tablets. Indian J Pharm Sci 2006;68: 301-307.
17. Talegaonkar S, Khan A, Khar R, Ahmad F, Khan Z. Development and characterization of paracetamol complexes with hydroxypropyl-β- cyclodextrin. Iranian J Pharm Res 2007;6:95-99
18. Jug M, Becirevic-Lacan M. Influence of hydroxypropyl-β-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur J Pharm Sci 2004;21:251-260